Country: United States
Language: English
Source: NLM (National Library of Medicine)
BUSPIRONE HYDROCHLORIDE (UNII: 207LT9J9OC) (BUSPIRONE - UNII:TK65WKS8HL)
STAT RX USA LLC
BUSPIRONE HYDROCHLORIDE
BUSPIRONE HYDROCHLORIDE 7.5 mg
ORAL
PRESCRIPTION DRUG
Buspirone hydrochloride tablets are indicated for the management of anxiety disorders or the short-term relief of the symptoms of anxiety. Anxiety or tension associated with the stress of everyday life usually does not require treatment with an anxiolytic. The efficacy of buspirone hydrochloride has been demonstrated in controlled clinical trials of outpatients whose diagnosis roughly corresponds to Generalized Anxiety Disorder (GAD). Many of the patients enrolled in these studies also had coexisting depressive symptoms and buspirone relieved anxiety in the presence of these coexisting depressive symptoms. The patients evaluated in these studies had experienced symptoms for periods of 1 month to over 1 year prior to the study, with an average symptom duration of 6 months. Generalized Anxiety Disorder (300.02) is described in the American Psychiatric Association's Diagnostic and Statistical Manual, III1 as follows: Generalized, persistent anxiety (of at least 1 month continual duration), manifested by symptom
Buspirone hydrochloride Tablets, USP, 7.5 mg (off-white, oval shaped tablet debossed with “Par 725” bisected on one side and “7.5” on the other side. 7.5 mg tablets NDC 49884-725-01 Bottles of 100 NDC 49884-725-05 Bottles of 500 Store at 25° C (77° F); excursions permitted between 15° C to 30° C (59° F to 86° F) [see USP controlled room temperature]. Dispense in tight, light-resistant container (USP).
Abbreviated New Drug Application
BUSPIRONE HYDROCHLORIDE - BUSPIRONE HYDROCHLORIDE TABLET STAT RX USA LLC ---------- DESCRIPTION Buspirone hydrochloride, USP is an antianxiety agent that is not chemically or pharmacologically related to the benzodiazepines, barbiturates, or other sedative/anxiolytic drugs. Buspirone hydrochloride is a white crystalline, water soluble compound with a molecular weight of 422.0. Chemically, buspirone hydrochloride is 8-[4-[4-(2-Pyrimidinyl)-1-piperazinyl]butyl]-8- azaspiro[4.5]decane-7,9-dione monohydrochloride. The molecular formula C H N O • HCl is represented by the following structural formula: Buspirone hydrochloride is supplied as tablets for oral administration containing 7.5 mg of buspirone hydrochloride USP. Buspirone hydrochloride tablets contain the following inactive ingredients: lactose monohydrate, magnesium stearate, microcrystalline cellulose, povidone, and sodium starch glycolate. CLINICAL PHARMACOLOGY The mechanism of action of buspirone is unknown. Buspirone differs from typical benzodiazepine anxiolytics in that it does not exert anticonvulsant or muscle relaxant effects. It also lacks the prominent sedative effect that is associated with more typical anxiolytics. _In vitro _preclinical studies have shown that buspirone has a high affinity for serotonin (5-HT ) receptors. Buspirone has no significant affinity for benzodiazepine receptors and does not affect GABA binding _in vitro _or _in vivo _when tested in preclinical models. Buspirone has moderate affinity for brain D2-dopamine receptors. Some studies do suggest that buspirone may have indirect effects on other neurotransmitter systems. Buspirone hydrochloride is rapidly absorbed in man and undergoes extensive first-pass metabolism. In a radio-labeled study, unchanged buspirone in the plasma accounted for only about 1% of the radioactivity in the plasma. Following oral administration, plasma concentrations of unchanged Buspirone are very low and variable between subjects. Peak plasma levels of 1ng/mL to 6 ng/mL have been observed 40 to 90 m Read the complete document